View in EDS

Advancing COPD management through novel pharmacological agents: ensifentrine and dupilumab.

Saved in:
Bibliographic Details
Title: Advancing COPD management through novel pharmacological agents: ensifentrine and dupilumab.
Authors: Walkon LL; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Burmeister JR; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Nazmifar M; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Bohler F; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Kochanowska-Karamyan A; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Allen SA; Pulmonology Critical Care Medicine, Corewell Health Beaumont Troy Hospital, Troy, MI, USA.
Source: Breathe (Sheffield, England) [Breathe (Sheff)] 2025 Dec 16; Vol. 21 (4), pp. 250206. Date of Electronic Publication: 2025 Dec 16 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 101231007 Publication Model: eCollection Cited Medium: Print ISSN: 1810-6838 (Print) Linking ISSN: 18106838 NLM ISO Abbreviation: Breathe (Sheff) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1810-6838
DOI:10.1183/20734735.0206-2025